CG
DNA icon

Cutler Group’s Ginkgo Bioworks DNA Stock Holding History

Cutler Group’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,763
Closed -$4K – 3979
2022
Q4 		$4K Sell
1,763
-1,060
-38% -$97.5K ﹤0.01% 3279
2022
Q3 		$20K Buy
2,823
+2,218
+367% +$264K ﹤0.01% 2602
2022
Q2 		$2K Sell
605
-460
-43% -$56.1K ﹤0.01% 4258
2022
Q1 		$9K Sell
1,065
-1,618
-60% -$315K ﹤0.01% 3685
2021
Q4 		$59K Buy
2,683
+788
+42% +$374K ﹤0.01% 2266
2021
Q3 		$61K Buy
+1,895
New +$922K ﹤0.01% 2343

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cutler Group's DNA Position: Q1 2024 in Review

Cutler Group reduced its Ginkgo Bioworks (DNA) stake by 2.5% in Q1 2024, selling an estimated $259 and leaving 193 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #1366.

Cutler Group first reported a position in DNA in Q3 2021 and has held it in 11 quarters since. The position peaked at $233K in Q3 2021. 342 funds tracked by Wall St. Rank hold DNA as of Q1 2024.

  • Cutler Group held 193 shares of Ginkgo Bioworks worth $8K as of Q1 2024.
  • Cutler Group sold 5 Ginkgo Bioworks shares in Q1 2024, an estimated $259.
  • Ginkgo Bioworks made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1366 holding.
  • Cutler Group first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 11 quarters since.
  • Cutler Group's Ginkgo Bioworks position peaked at $233K in Q3 2021.
  • 342 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.